Lack of Survival Benefit in Patients with Anaplastic Astrocytoma Treated with Temozolomide during Radiotherapy

MLA

Timothy A. Chan, et al. “Lack of Survival Benefit in Patients with Anaplastic Astrocytoma Treated with Temozolomide during Radiotherapy.” International Journal of Radiation Oncology*Biology*Physics, vol. 81, Oct. 2011, p. S269. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2011.06.463.

APA

Timothy A. Chan, Maria Chang, C.A. Barker, & K. Beal. (2011). Lack of Survival Benefit in Patients with Anaplastic Astrocytoma Treated with Temozolomide during Radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 81, S269. https://doi.org/10.1016/j.ijrobp.2011.06.463

Chicago

Timothy A. Chan, Maria Chang, C.A. Barker, and K. Beal. 2011. “Lack of Survival Benefit in Patients with Anaplastic Astrocytoma Treated with Temozolomide during Radiotherapy.” International Journal of Radiation Oncology*Biology*Physics 81 (October): S269. doi:10.1016/j.ijrobp.2011.06.463.